SerumIgG,IgA,IgM,C3andC4weredeterminedbyneophelmetricimmunoassay,serumandbiliaryIL2,sIL2Rlevelsweremeasuredbyatwoantibodysandwichenzymelinkedimmunosorbentassayinpatientswithsimplegallbladdercarcinoma,withbothgallbladdercarcinomaandgallstone,withsimplegallstoneandhealthyindividuals.Theresultsshowedthat:①Comparedwithcontrols,thegallbladdercarcinomapatientshadobviouslyloweredserumandbiliarylevelsofIL2andCD+4cell;andtheypresentedamarkedincreasedserum,biliarylevelsofsIL2RandCD+8cell.②TherewascorrelationbetweenthelevelsofsIL2RandCD+8,IL2andCD+4inthepatientswithgallbladdercarcinomaandtheirclinicstage.③Comparedwiththepatientswithgallbladdercarcinoma,gallstonepatientspresentedamarkeddecreasedserumandbiliarylevelofsIl2RandCD+8cell,andamarkedincreasedserumandbiliarylevelofIL2andCD+4cell.Theresultssuggestthat:①Thepatientswithgallbladdercarcinomahaveimmunedepression;②Inthepatientswithgallbladdercarcinomaandgallstone,gallstoneasainjuryfactorbrokethebalancebetweenCD+4andCD+8,thebalancebetweenIL2anditsreceptor;③TcellsubpopulationandsIL2R,IL2levelsmaybeusedasmarkerstopredictthechangesinpatientswithgallbladdercarcinoma.
Citation：
JiaoXinyuan,ShiJingsen,GaoJinsong,etal.. DETERMINATIONOFLEVELSOFCELLULARIMMUNITYANDHUMORALIMMUNITYINPATIENTSWITHGALLBLADDERCARCINOMA. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 1999, 6(4): 227-229. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
LissoniP,BamiS,RovelliF,etal.Thebiologicalsignificanceofsolubleinterleukin2receptorinsolidtumors.EurJCancer,1990;26(1)∶33.
|
| 2. |
LeeWJ,ChangKJ,LeeCS,etal.SelectdepressionofTlymphocytesubsetsingastriccancerpatients:animplicationofimmunotherapy.JSurgOncol,1994;55(3)∶165.
|
| 3. |
ZengZC,TangZY,LiuKD,etal.ObservationofchangesinperipheralTlymphocytesubsetsbyflowcytometryinpatientswithlivercancertreatedwithradioimmunotherapy.NucMedCommun,1995;16(5)∶378.
|
| 4. |
RebinLA,Nelson.Thesolubleinterleukin2receptor:biology,functionandclinicalapplication.AnnInternMed,1990;113(8)∶619.
|
| 5. |
ButchAW,ChungCH.Cytokineexpressionbygerminalcentercells.JImmunol,1993;150(1)∶39.
|
| 6. |
LotzeMT,FinnOJ.Recentadvanceincellularimmunology:implicationsforimmunitytocancer.ImmunolToday,1990;11(4)∶190.
|
| 7. |
石景森,周连锁,王作仁等.830例肝外胆管癌的回顾性研究.中华外科杂志,1997;35(11)∶645.
|
| 8. |
Rabeneck.Gallstoneandbileductcancer.Gastroenterology,1991;107(10)∶1205.
|
| 9. |
HensorDE,AlboresSavedraJ,CorleD.Carcinomaofthegallbladder:histologic;stageofdisease,gradeandsurvivedrates.Cancer,1992;70(11)∶1483.
|
- 1. LissoniP,BamiS,RovelliF,etal.Thebiologicalsignificanceofsolubleinterleukin2receptorinsolidtumors.EurJCancer,1990;26(1)∶33.
- 2. LeeWJ,ChangKJ,LeeCS,etal.SelectdepressionofTlymphocytesubsetsingastriccancerpatients:animplicationofimmunotherapy.JSurgOncol,1994;55(3)∶165.
- 3. ZengZC,TangZY,LiuKD,etal.ObservationofchangesinperipheralTlymphocytesubsetsbyflowcytometryinpatientswithlivercancertreatedwithradioimmunotherapy.NucMedCommun,1995;16(5)∶378.
- 4. RebinLA,Nelson.Thesolubleinterleukin2receptor:biology,functionandclinicalapplication.AnnInternMed,1990;113(8)∶619.
- 5. ButchAW,ChungCH.Cytokineexpressionbygerminalcentercells.JImmunol,1993;150(1)∶39.
- 6. LotzeMT,FinnOJ.Recentadvanceincellularimmunology:implicationsforimmunitytocancer.ImmunolToday,1990;11(4)∶190.
- 7. 石景森,周连锁,王作仁等.830例肝外胆管癌的回顾性研究.中华外科杂志,1997;35(11)∶645.
- 8. Rabeneck.Gallstoneandbileductcancer.Gastroenterology,1991;107(10)∶1205.
- 9. HensorDE,AlboresSavedraJ,CorleD.Carcinomaofthegallbladder:histologic;stageofdisease,gradeandsurvivedrates.Cancer,1992;70(11)∶1483.
